Question follow-through · 70170

Cancer: Clinical Trials and Research

To ask the Secretary of State for Science, Innovation and Technology, what steps his Department is taking to ensure equitable regional access to national cancer (a) research funding and (b) clinical trial opportunities.

answeredDepartment for Science, Innovation and Technology

About this written question

A written question asks a government minister for information in writing. Parliament publishes the question and any answer.

Answering body
Department for Science, Innovation and Technology
Tabled
22 Jul 2025
Target answer date
1 Sept 2025
Answer
1 Sept 2025 · 41 calendar days after tabling

Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.

Recorded timeline

  1. 22 Jul 2025

    Question tabled

    To ask the Secretary of State for Science, Innovation and Technology, what steps his Department is taking to ensure equitable regional access to national cancer (a) research funding and (b) clinical trial opportunities.

  2. 1 Sept 2025

    Target answer date

    Date supplied by the official written-questions record.

  3. 1 Sept 2025

    Answer published

    Cancer research is a critical priority for the Government. The Government is committed to ensuring that all cancer patients across the UK have access to cutting-edge clinical trials and innovative, lifesaving treatments. The National Institute for Health ...

Open official record

Official data retrieved 28 Sept 2026.

Later records

Possible follow-up questions

Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Innovation and Research: EU Countries

16 Jun 2026 · To ask the Secretary of State for Science, Innovation and Technology, what estimate he has made of the economic benefit to the United Kingdom of increased participation in European research, development and innovation partnerships.